Effect of neoadjuvant chemotherapy regimen choice in patients with breast cancer with pathologic complete response. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract ...
"Our main conclusion is that more research is needed to better investigate multimodality therapies and individualize therapy for these high-risk patients…There’s a clear need to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results